UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 187

Sortiert nach

Accuracy of Humanitas Ultrasound Criteria in Assessing Disease Activity and Severity in Ulcerative Colitis: A Prospective Study

Journal of Crohn's and colitis, 2018-11, Vol.12 (12), p.1385-1391

2018

Link zum Volltext

Verfügbarkeit prüfen

A Reliability Study: Strong Inter-Observer Agreement of an Expert Panel for Intestinal Ultrasound in Ulcerative Colitis

Journal of Crohn's and colitis, 2021-08, Vol.15 (8), p.1284-1290

2021

Link zum Volltext

Verfügbarkeit prüfen

Ultrasonography in inflammatory bowel disease – So far we are?

United European gastroenterology journal, 2022-03, Vol.10 (2), p.225-232

2022

Link zum Volltext

Verfügbarkeit prüfen

Anti-IL-6 treatment for inflammatory bowel diseases: next cytokine, next target

Current drug targets, 2013-11, Vol.14 (12), p.1508

2013

Link zum Volltext

Verfügbarkeit prüfen

Absence of COVID-19 Infection in Patients Accessing IBD Unit at Humanitas, Milan: Implications for Postlockdown Measures

The American journal of gastroenterology, 2020-10, Vol.115 (10), p.1719-1721

2020

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-23 Blockers: Born to be First-line Biologic Agents in Inflammatory Bowel Disease?

Current pharmaceutical design, 2019-01, Vol.25 (1), p.25

2019

Link zum Volltext

Verfügbarkeit prüfen

SFED recommendations for IBD endoscopy during COVID-19 pandemic: Italian and French experience

Nature reviews. Gastroenterology & hepatology, 2020-08, Vol.17 (8), p.507-516

2020

Link zum Volltext

Verfügbarkeit prüfen

Gastrointestinal System: COVID-19 and Potential Mechanisms Associated with Coagulopathy

Current drug targets, 2022-01, Vol.23 (17), p.1611

2022

Link zum Volltext

Verfügbarkeit prüfen

Rediscovering histology: what is new in endoscopy for inflammatory bowel disease?

Therapeutic Advances in Gastroenterology, 2021, Vol.14, p.17562848211005692-17562848211005692

2021

Link zum Volltext

Verfügbarkeit prüfen

Biosimilars of Adalimumab in Inflammatory Bowel Disease: Are we Ready for that?

Current pharmaceutical design, 2019-01, Vol.25 (1), p.7

2019

Link zum Volltext

Verfügbarkeit prüfen

The safety of biological pharmacotherapy for the treatment of ulcerative colitis

Expert opinion on drug safety, 2017-04, Vol.16 (4), p.437-443

2017

Link zum Volltext

Verfügbarkeit prüfen

S902 Intestinal Ultrasound Response and Transmural Remission After 48 Weeks of Treatment With Ustekinumab in Crohn’s Disease: STARDUST Trial Substudy Results by Line of Treatment and by Location

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S426-S426

2021

Link zum Volltext

Verfügbarkeit prüfen

Gut Microbiota Metabolites: Unveiling Their Role in Inflammatory Bowel Diseases and Fibrosis

Pharmaceuticals (Basel, Switzerland), 2024-03, Vol.17 (3), p.347

2024

Link zum Volltext

Verfügbarkeit prüfen

Treat-to-Target and Regular Surveillance of Inflammatory Bowel Disease Are Associated with Low Incidence and Early-Stage Detection of Malignancies: A Retrospective Cohort Study

Cancers, 2023-12, Vol.15 (24), p.5754

2023

Link zum Volltext

Verfügbarkeit prüfen

The Management of Postoperative Recurrence in Crohn's Disease

Journal of clinical medicine, 2023-12, Vol.13 (1), p.119

2023

Link zum Volltext

Verfügbarkeit prüfen

The Earlier You Find, the Better You Treat: Red Flags for Early Diagnosis of Inflammatory Bowel Disease

Diagnostics (Basel), 2023-10, Vol.13 (20), p.3183

2023

Link zum Volltext

Verfügbarkeit prüfen

New Technologies in Digestive Endoscopy for Ulcerative Colitis Patients

Biomedicines, 2023-07, Vol.11 (8), p.2139

2023

Link zum Volltext

Verfügbarkeit prüfen

Histological Scores in Patients with Inflammatory Bowel Diseases: The State of the Art

Journal of clinical medicine, 2022-02, Vol.11 (4), p.939

2022

Link zum Volltext

Verfügbarkeit prüfen

Editorial: an accurate, reliable and responsive ultrasound activity score for Crohn’s disease? Sounds good to US. Authors' reply

Alimentary pharmacology & therapeutics, 2022-02, Vol.55 (3), p.362-363

2022

Link zum Volltext

Verfügbarkeit prüfen

Bowel Ultrasound in Inflammatory Bowel Disease: How Far in the Grayscale?

Life (Basel, Switzerland), 2021-07, Vol.11 (7), p.649

2021

Link zum Volltext

Verfügbarkeit prüfen

Reply

Clinical gastroenterology and hepatology, 2022-02, Vol.20 (2), p.e346

2022

Link zum Volltext

Verfügbarkeit prüfen

Complementary and alternative medicine in inflammatory bowel diseases: what is the future in the field of herbal medicine?

Expert review of gastroenterology & hepatology, 2014-09, Vol.8 (7), p.835-846

2014

Link zum Volltext

Verfügbarkeit prüfen

Anemia in Inflammatory Bowel Disease: The Opening of Pandora’s Box?

Clinical gastroenterology and hepatology, 2015-10, Vol.13 (10), p.1767-1769

2015

Link zum Volltext

Verfügbarkeit prüfen

Artificial Endoscopy and Inflammatory Bowel Disease: Welcome to the Future

Journal of clinical medicine, 2022-01, Vol.11 (3), p.569

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of S1P1 Receptor Modulator Drugs for Patients with Moderate-to-Severe Ulcerative Colitis

Journal of clinical medicine, 2023-07, Vol.12 (15), p.5014

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 187

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(183)
Mit Volltextzugriff
(145)

Publikationsform

Artikel
(186)
Buchkapitel
(1)

Sprache

Englisch
(187)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(9)
... seit 90 Tagen
(15)

Menü

Weitere Dienste

Einstellungen

Accuracy of Humanitas Ultrasound Criteria in Assessing Disease Activity and Severity in Ulcerative Colitis: A Prospective Study

A Reliability Study: Strong Inter-Observer Agreement of an Expert Panel for Intestinal Ultrasound in Ulcerative Colitis

Ultrasonography in inflammatory bowel disease – So far we are?

Anti-IL-6 treatment for inflammatory bowel diseases: next cytokine, next target

Absence of COVID-19 Infection in Patients Accessing IBD Unit at Humanitas, Milan: Implications for Postlockdown Measures

Interleukin-23 Blockers: Born to be First-line Biologic Agents in Inflammatory Bowel Disease?

SFED recommendations for IBD endoscopy during COVID-19 pandemic: Italian and French experience

Gastrointestinal System: COVID-19 and Potential Mechanisms Associated with Coagulopathy

Rediscovering histology: what is new in endoscopy for inflammatory bowel disease?

Biosimilars of Adalimumab in Inflammatory Bowel Disease: Are we Ready for that?

The safety of biological pharmacotherapy for the treatment of ulcerative colitis

S902 Intestinal Ultrasound Response and Transmural Remission After 48 Weeks of Treatment With Ustekinumab in Crohn’s Disease: STARDUST Trial Substudy Results by Line of Treatment and by Location

Gut Microbiota Metabolites: Unveiling Their Role in Inflammatory Bowel Diseases and Fibrosis

Treat-to-Target and Regular Surveillance of Inflammatory Bowel Disease Are Associated with Low Incidence and Early-Stage Detection of Malignancies: A Retrospective Cohort Study

The Management of Postoperative Recurrence in Crohn's Disease

The Earlier You Find, the Better You Treat: Red Flags for Early Diagnosis of Inflammatory Bowel Disease

New Technologies in Digestive Endoscopy for Ulcerative Colitis Patients

Histological Scores in Patients with Inflammatory Bowel Diseases: The State of the Art

Editorial: an accurate, reliable and responsive ultrasound activity score for Crohn’s disease? Sounds good to US. Authors' reply

Bowel Ultrasound in Inflammatory Bowel Disease: How Far in the Grayscale?

Reply

Complementary and alternative medicine in inflammatory bowel diseases: what is the future in the field of herbal medicine?

Anemia in Inflammatory Bowel Disease: The Opening of Pandora’s Box?

Artificial Endoscopy and Inflammatory Bowel Disease: Welcome to the Future

Efficacy and Safety of S1P1 Receptor Modulator Drugs for Patients with Moderate-to-Severe Ulcerative Colitis

Suchergebnisse filtern